Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


11.03.2024

3 Antimicrob Agents Chemother
4 Antiviral Res
1 BMC Pediatr
3 BMJ
2 Epidemiol Infect
2 Eur J Epidemiol
1 J Immunol
10 J Infect Dis
2 JAMA
2 MMWR Morb Mortal Wkly Rep
9 Pediatrics
1 PLoS Med
18 PLoS One
1 Proc Natl Acad Sci U S A
3 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. YANG H, Yu X, Hou W, Liu X, et al
    Effectiveness and safety of nirmatrelvir-ritonavir in kidney transplant recipients with severe kidney dysfunction infected with COVID-19.
    Antimicrob Agents Chemother. 2024 Jan 30:e0138423. doi: 10.1128/aac.01384.
    PubMed         Abstract available

  2. ZHANG R, Zhou J, Yan H, Liu X, et al
    Manidipine is not a potential inhibitor against SARS-CoV-2 main protease.
    Antimicrob Agents Chemother. 2024;68:e0129723.
    PubMed        

  3. MIAH M, Davis AM, Hannoun C, Said JS, et al
    Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus.
    Antimicrob Agents Chemother. 2024;68:e0106423.
    PubMed         Abstract available


    Antiviral Res

  4. GOTO T, Kawai N, Bando T, Takasaki Y, et al
    Virological and clinical outcomes in outpatients treated with baloxavir or neuraminidase inhibitors for A(H3N2) influenza: A multicenter study of the 2022-2023 season.
    Antiviral Res. 2024;224:105853.
    PubMed         Abstract available

  5. SINHA D, Yaugel-Novoa M, Waeckel L, Paul S, et al
    Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses.
    Antiviral Res. 2024 Feb 6:105823. doi: 10.1016/j.antiviral.2024.105823.
    PubMed         Abstract available

  6. WINIGER RR, Perez L
    Therapeutic antibodies and alternative formats against SARS-CoV-2.
    Antiviral Res. 2024 Jan 31:105820. doi: 10.1016/j.antiviral.2024.105820.
    PubMed         Abstract available

  7. BOGACHEVA MS, Kuivanen S, Potdar S, Hassinen A, et al
    Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
    Antiviral Res. 2024 Jan 23:105813. doi: 10.1016/j.antiviral.2024.105813.
    PubMed         Abstract available


    BMC Pediatr

  8. CUI J, Jia W, Li P, Zhang X, et al
    Influenza a H1N1 infection complicated with encephalopathy and acute pancreatitis: a case report.
    BMC Pediatr. 2024;24:156.
    PubMed         Abstract available


    BMJ

  9. WATTERSON A
    What we did not learn at the covid inquiry in Scotland: a gap analysis.
    BMJ. 2024;384:q491.
    PubMed        

  10. AGIUS RM
    UK workers during the pandemic: inadequate protection and, consequently, increased risk.
    BMJ. 2024;384:q508.
    PubMed        

  11. WISE J
    Covid-19 taskforce called for a new national vaccine agency to prepare for future pandemics.
    BMJ. 2024;384:q534.
    PubMed        


    Epidemiol Infect

  12. BIRD O, Galiza EP, Baxter DN, Boffito M, et al
    The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
    Epidemiol Infect. 2024;152:e37.
    PubMed         Abstract available

  13. WAITE LL, Nahhas A, Irvahn J, Garden G, et al
    COVID-19 passenger screening to reduce travel risk and translocation of disease.
    Epidemiol Infect. 2024;152:e36.
    PubMed         Abstract available


    Eur J Epidemiol

  14. NORSTROM T, Ramstedt M
    The impact of the COVID-19 pandemic on mortality in Sweden-Did it differ across socioeconomic groups?
    Eur J Epidemiol. 2024;39:137-145.
    PubMed         Abstract available

  15. YANG L, Chen W, Chen D, He J, et al
    Cohort profile: the China surgery and anesthesia cohort (CSAC).
    Eur J Epidemiol. 2024;39:207-218.
    PubMed         Abstract available


    J Immunol

  16. READ KA, Amici SA, Farsi S, Cutcliffe M, et al
    PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center Responses during Influenza Virus Infection.
    J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270.
    PubMed         Abstract available


    J Infect Dis

  17. EGESKOV-CAVLING AM, Johannesen CK, Lindegaard B, Fischer TK, et al
    Underreporting and Misclassification of Respiratory Syncytial Virus-Coded Hospitalization Among Adults in Denmark Between 2015-2016 and 2017-2018.
    J Infect Dis. 2024;229.
    PubMed         Abstract available

  18. SHEIKH Z, Potter E, Li Y, Cohen RA, et al
    Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A Systematic Review.
    J Infect Dis. 2024;229.
    PubMed         Abstract available

  19. OSEI-YEBOAH R, Zhu F, Wang X, Nair H, et al
    Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels Among Children and Adults in Scotland.
    J Infect Dis. 2024;229.
    PubMed         Abstract available

  20. KENMOE S, Chu HY, Dawood FS, Milucky J, et al
    Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections During Pregnancy.
    J Infect Dis. 2024;229.
    PubMed         Abstract available

  21. VAN ROEKEL C, Poukka E, Turunen T, Nohynek H, et al
    Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study.
    J Infect Dis. 2024;229.
    PubMed         Abstract available

  22. CHAPPIN K, Besteman SB, Hennus MP, Wildenbeest JG, et al
    Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection.
    J Infect Dis. 2024;229.
    PubMed         Abstract available

  23. OSEI-YEBOAH R, Johannesen CK, Egeskov-Cavling AM, Chen J, et al
    Respiratory Syncytial Virus-Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study.
    J Infect Dis. 2024;229.
    PubMed         Abstract available

  24. JOHNSON M, Chelysheva I, Oner D, McGinley J, et al
    A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants.
    J Infect Dis. 2024;229.
    PubMed         Abstract available

  25. HAK SF, Venekamp RP, Billard MN, van Houten MA, et al
    Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study.
    J Infect Dis. 2024;229.
    PubMed         Abstract available

  26. LIM WW, Shuo F, Wong SS, Sullivan SG, et al
    Hemagglutination inhibition antibody titers mediate influenza vaccine efficacy against symptomatic influenza A(H1N1), A(H3N2), and B/Victoria infections.
    J Infect Dis. 2024 Mar 7:jiae122. doi: 10.1093.
    PubMed         Abstract available


    JAMA

  27. HARRIS E
    Millions of US Children Experience Range of Long COVID Effects.
    JAMA. 2024;331:726.
    PubMed        

  28. RUBIN R
    When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike.
    JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  29. DECUIR J, Payne AB, Self WH, Rowley EAK, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged >/=18 Years - VISION and IVY Networks,
    MMWR Morb Mortal Wkly Rep. 2024;73:180-188.
    PubMed         Abstract available

  30. ESSER MB, Sherk A, Liu Y, Naimi TS, et al
    Deaths from Excessive Alcohol Use - United States, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2024;73:154-161.
    PubMed         Abstract available


    Pediatrics

  31. YONTS AB, Gaviria-Agudelo C, Kimberlin DW, O'Leary ST, et al
    Fall 2023 ACIP Update on Meningococcal, RSV, COVID-19, and Other Pediatric Vaccines.
    Pediatrics. 2023 Dec 14. doi: 10.1542/peds.2023-064990.
    PubMed         Abstract available

  32. CURNS AT, Rha B, Lively JY, Sahni LC, et al
    Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020.
    Pediatrics. 2024;153:e2023062574.
    PubMed         Abstract available

  33. VANDERMORRIS A, Toulany A, McKinnon B, Tam MW, et al
    Sexual and Reproductive Health Outcomes Among Adolescent Females During the COVID-19 Pandemic.
    Pediatrics. 2024;153:e2023063889.
    PubMed         Abstract available

  34. GRUBB LK
    Sexual and Reproductive Health During the Pandemic: Vulnerable Populations Are Hit the Hardest.
    Pediatrics. 2024;153:e2023064523.
    PubMed        

  35. RAO S, Gross RS, Mohandas S, Stein CR, et al
    Postacute Sequelae of SARS-CoV-2 in Children.
    Pediatrics. 2024;153:e2023062570.
    PubMed         Abstract available

  36. CARDEMIL CV, Cao Y, Posavad CM, Badell ML, et al
    Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
    Pediatrics. 2024 Feb 9:e2023064252. doi: 10.1542/peds.2023-064252.
    PubMed         Abstract available

  37. AHMED A, Munoz FM, Muller WJ, Agwu A, et al
    Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.
    Pediatrics. 2024;153:e2023063775.
    PubMed         Abstract available

  38. FRINTNER MP, Leslie LK, Gottschlich EA, Starmer AJ, et al
    Pediatricians' Career Satisfaction and Wellbeing by Sex Before and During the COVID-19 Pandemic.
    Pediatrics. 2024;153:e2023063345.
    PubMed         Abstract available

  39. CHUA KP, Volerman A, Zhang J, Hua J, et al
    Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022.
    Pediatrics. 2024;153:e2023064245.
    PubMed         Abstract available


    PLoS Med

  40. MKOMA GF, Agyemang C, Benfield T, Rostila M, et al
    Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in Denmark.
    PLoS Med. 2024;21:e1004280.
    PubMed         Abstract available


    PLoS One

  41. MANACAS LRA, Amorim RLO, Aguila A, Novo PC, et al
    Evaluation of hematological changes and immune response biomarkers as a prognostic factor in critical patients with COVID-19.
    PLoS One. 2024;19:e0297490.
    PubMed         Abstract available

  42. MADRAZO L, Choo-Foo J, Domecq MC, LaDonna KA, et al
    Illness presenteeism among physicians and trainees: Study protocol of a scoping review.
    PLoS One. 2024;19:e0297447.
    PubMed         Abstract available

  43. CONOLLY AR, Maben J, Abrams R, Harris R, et al
    'There was a pivotal moment'. The dynamics, transitions, adaptations and trajectories of nursing at the front-line in the UK during the COVID-19 pandemic.
    PLoS One. 2024;19:e0295394.
    PubMed         Abstract available

  44. HEDDEN L, Spencer S, Mathews M, Gard Marshall E, et al
    "Technology has allowed us to do a lot more but it's not necessarily the panacea for everybody": Family physician perspectives on virtual care during the COVID-19 pandemic and beyond.
    PLoS One. 2024;19:e0296768.
    PubMed         Abstract available

  45. SEALE H, Harris-Roxas B, Heywood AE, Abdi I, et al
    "It's no use saying it in English": A qualitative study exploring community leaders' perceptions of the challenges and opportunities with translating and interpreting COVID-19 related public health messaging to reach ethnic minorities in Australia.
    PLoS One. 2024;19:e0284000.
    PubMed         Abstract available

  46. BRESSER M, Erhardt RM, Shanaube K, Simwinga M, et al
    Evaluation of COVID-19 antigen rapid diagnostic tests for self-testing in Lesotho and Zambia.
    PLoS One. 2024;19:e0280105.
    PubMed         Abstract available

  47. PRADO ADS, Baldofski S, Kohls E, Rummel-Kluge C, et al
    International and domestic university students' mental health over the course of the COVID-19 pandemic in Germany: Comparison between 2020, 2021, and 2022.
    PLoS One. 2024;19:e0299812.
    PubMed         Abstract available

  48. HOOKHAM L, Cantrell L, Cose S, Freyne B, et al
    Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi.
    PLoS One. 2024;19:e0290913.
    PubMed         Abstract available

  49. CHARQUERO-BALLESTER M, Walter JG, Rybner AS, Nissen IA, et al
    Emotions on Twitter as crisis imprint in high-trust societies: Do ambient affiliations affect emotional expression during the pandemic?
    PLoS One. 2024;19:e0296801.
    PubMed         Abstract available

  50. BUMYUT A, Thanapop S, Dwipayanti NMU
    Safety and health measures compliance during the COVID-19 pandemic for community-based tourism in Nakhon Si Thammarat, Thailand: A cross-sectional descriptive study.
    PLoS One. 2024;19:e0300030.
    PubMed         Abstract available

  51. LWIN MO, Sheldenkar A, Tng PL
    You must be myths-taken: Examining belief in falsehoods during the COVID-19 health crisis.
    PLoS One. 2024;19:e0294471.
    PubMed         Abstract available

  52. CRUICKSHANK M, Brazzelli M, Manson P, Torrance N, et al
    What is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence.
    PLoS One. 2024;19:e0299743.
    PubMed         Abstract available

  53. DOMNICH A, Calabro GE
    Epidemiology and burden of respiratory syncytial virus in Italian adults: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297608.
    PubMed         Abstract available

  54. KECHAGIAS KS, Laleye JD, Drmota J, Geropoulos G, et al
    Minimal change disease following COVID-19 vaccination: A systematic review.
    PLoS One. 2024;19:e0297568.
    PubMed         Abstract available

  55. GROSSMANN K, Risch M, Markovic A, Aeschbacher S, et al
    Sex-specific differences in physiological parameters related to SARS-CoV-2 infections among a national cohort (COVI-GAPP study).
    PLoS One. 2024;19:e0292203.
    PubMed         Abstract available

  56. SOW MS, Togo J, Simons LM, Diallo ST, et al
    Genomic characterization of SARS-CoV-2 in Guinea, West Africa.
    PLoS One. 2024;19:e0299082.
    PubMed         Abstract available

  57. HU X, Zhu B, Zhang B, Zeng L, et al
    Extreme risk spillovers between US and Chinese agricultural futures markets in crises: A dependence-switching copula-CoVaR model.
    PLoS One. 2024;19:e0299237.
    PubMed         Abstract available

  58. OCANA GUTIERREZ VR, Gonzalez Ramirez RA, Ocana Aguilar VA, Ocana Aguilar NG, et al
    The weekly P25 of the age of the influenza-like illness shows a higher correlation with COVID-19 mortality than rapid tests and could predict the evolution of COVID-19 pandemics in sentinel surveillance, Piura, Peru, 2021.
    PLoS One. 2024;19:e0295309.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  59. KRETSCH RC, Xu L, Zheludev IN, Zhou X, et al
    Tertiary folds of the SL5 RNA from the 5' proximal region of SARS-CoV-2 and related coronaviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2320493121.
    PubMed         Abstract available


    Virus Res

  60. ZHANG S, Wang P, Shi L, Wang C, et al
    Exploring COVID-19 causal genes through disease-specific Cis-eQTLs.
    Virus Res. 2024;342:199341.
    PubMed         Abstract available

  61. MONTENEGRO AFL, Clementino MAF, Yaochite JNU
    Type I interferon pathway genetic variants in severe COVID-19.
    Virus Res. 2024;342:199339.
    PubMed         Abstract available

  62. LIM T, Rajoriya S, Kim B, Natasha A, et al
    In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted reactive oxygen species scavenger, against severe acute respiratory syndrome coronavirus 2 and multiple zoonotic viruses.
    Virus Res. 2024;342:199325.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.